SPRING CREEK CAPITAL LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 5:03 pm Sale |
2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
SPRING CREEK CAPITAL LLC | 0 0.000% |
-35,610 (Position Closed) |
Filing |
| 2022-10-27 4:07 pm Purchase |
2022-10-20 | 13G | Calidi Biotherapeutics, Inc. CLDI |
SPRING CREEK CAPITAL LLC | 35,610 8.600% |
35,610 (New Position) |
Filing |